English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

1. Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. 2. Infectious Diseases Department, Auckland City Hospital, Auckland, New Zealand. 3. Department of Internal Medicine, University of California San Diego, California, United States. 4. CIC De Vaccinologie Cochin-Pasteur, Hopital Cochin, Paris, France. 5. Department of Infectious Diseases, Ospedale Papa Giovanni XXIII, Bergamo, Italy. 6. Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Fla 7. Department of Medicine, Vanderbilt University Medical Center, Nashville TN 37232 8.Department of Pharmacology, Vanderbilt University School of Medicine, Nashville TN 37232 9. Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia

The HLA-B*53 / HLA-C*04 Haplotype is Strongly Associated with DRESS Syndrome during Treatment with Raltegravir.

The HLA-B53 / HLA-C04 Haplotype is Strongly Associated with DRESS Syndrome during Treatment with Raltegravir.